Potential Global Impact of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure

By sjmartinez • April 18, 2023

Talha KM, Butler J, Greene SJ, Aggarwal R, Anker SD, Claggett BL, Docherty KF, Solomon SD, McMurray JJV, Januzzi JL Jr, Vaduganathan M, Fonarow GC. Potential Global Impact of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure. Eur J Heart Fail. 2023 Apr 16. doi: 10.1002/ejhf.2864. Epub ahead of print. PMID: 37062865.

Tags: Cardiology/Epi, cardiovascular death, global, heart failure, Hospitalization, Implementation, Publications, sodium-glucose cotransporter-2

Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status

Lu F, Ahmed AA, Zhang S, Raman VK, Patel SS, Vargas JD, Fonarow GC, Heidenreich PA, Cleland JGF, Anker SD, Böhm M, Metra M, Zile[...]

Heart Failure with Preserved Ejection Fraction in Women: Sex-Specific Insights Across the Continuum from Diagnosis to Outcomes

Andrade-Bucknor S, Barforoshi S, Le DE, Lyubarova R, Chung J. Heart Failure with Preserved Ejection Fraction in Women: Sex-Specific Insights Across the Continuum from Diagnosis[...]

Transthyretin Cardiac Amyloidosis in an Older Athlete

O'Brien D, Reiss RA. Transthyretin Cardiac Amyloidosis in an Older Athlete. Cureus. 2026 Jun 29;18(6):e111747. doi: 10.7759/cureus.111747. PMID: 42534173; PMCID: PMC13419844.